The total return over the past 12 months is -96.49% vs. +16.94% for the S&P 500. So far it's up -79.31% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (96.37%) | (87.74%) | (86.30%) | (79.10%) | N/A | N/A |
| Total Return CAGR | (96.49%) | (87.88%) | (86.39%) | (79.17%) | N/A | N/A |
| Revenue CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Decoy Therapeutics Inc. (DCOY)
| Year | Start price | End price | DCOY Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $7.79 | $1.67 | (79.31%) | +14.51% | (93.82%) |
| 2025 | $331.20 | $7.79 | (97.64%) | +17.72% | (115.36%) |
| 2024 | $936.00 | $331.20 | (64.61%) | +24.89% | (89.50%) |
| 2023 | $2,203.20 | $936.00 | (57.51%) | +26.19% | (83.70%) |
| 2022 | $17,841.60 | $2,203.20 | (87.65%) | (18.17%) | (69.48%) |
| 2021 | $32,760.00 | $17,841.60 | (45.54%) | +28.74% | (74.28%) |
| 2020 | $136,080.00 | $32,760.00 | (75.93%) | +18.37% | (94.30%) |
| 2019 | $297,000.00 | $136,080.00 | (54.18%) | +31.22% | (85.40%) |
| 2018 | $3,141,000.00 | $297,000.00 | (90.54%) | (4.56%) | (85.98%) |
| 2017 | $4,752,000.00 | $3,141,000.00 | (33.90%) | +21.70% | (55.60%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
